Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 May 2023 for Danimer Scientific, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Stephen Croskrey: trading record in brief
This profile gathers the share dealings of Stephen Croskrey in Danimer Scientific, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 29 December 2020 to 18 April 2022, the count stands at 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 12 May 2023 came the latest disclosure, a share grant in Danimer Scientific, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Croskrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
39,333 sharesClass A Common StockSEC:0001209191-23-029172:0
98,968 shares@ US$8.20100.0% of flowClass A Common Stock ("Common Stock")SEC:0001213900-22-000535:0
285,326 sharesClass A Common Stock ("Common Stock")SEC:0001213900-21-048926:0
3 of 3 declarations
